Four new plastoquinones, together with two known compounds, sargahydroquinoic acid and sargaquinoic acid, were isolated from the brown alga, Sargassum yezoense collected from the eastern coast of Korea. The structures of these compounds were elucidated based on spectroscopic analyses including NMR and MS. Their structures designated as meroterphenol A (1), B (2), C (3) and D (4) were characterized by a 6-methyl-1,4-benzohydroquinone moiety with an oxygenated diterpenoic acid chain. Meroterphenols A-D showed potent activation effects on peroxisome proliferator-activated receptor gamma (PPARg g).
Marine natural products are characterized by a large chemical diversity and potent biological activities. Research on the secondary metabolites of marine organisms is recognized as an effective scientific approach to the discovery of new pharmacophores. 1, 2) The algae are a representative marine resource showing potent biological activities and some of them, such as Laminaria, Undaria, Porphyra, are famous as foods that include various essential nutrients. 3, 4) The genus Sargassum (Sargassaceae), a large brown alga, possesses nearly 400 species distributed in the temperate zone of the Indian Ocean, the west coast of the Pacific Ocean and the coast of Australia. 5) Several prenylated quinones and carotenoids have been reported as major components of this genus. [6] [7] [8] [9] Its extracts and secondary metabolites possess mainly anti-oxidative and anti-proliferator activities. [9] [10] [11] Six Sargassum species were collected from the eastern coast of Korea in order to evaluate their biological activities, and Sargassum yezoense (YAMADA, YOSHIDA et KONNO) showed potent anti-oxidative and peroxisome proliferator activated receptor (PPAR) inducing activities. It was known that S. yezoense possessed an antioxidant effect, which was attributable to sargahydroquinoic acid and sargaquinoic acid, 9, 11) but no research on their PPAR-inducing activity was reported.
Peroxisome proliferator activator receptor (PPAR)g, one of the subtypes of the PPAR family, is a member of the nuclear receptor (NR) family of ligand-dependent transcription factors that plays essential roles in lipid homeostasis and energy metabolism. [12] [13] [14] [15] PPARg is mainly present in the adipose tissue, skeletal muscle, and liver. 16) Two other family members include PPARa which is present in the liver, kidney and heart, and the ubiquitously-expressed PPARb/d. 17) Upon ligand binding, all three of the mammalian isotypes bind to PPAR responsive elements (PPRE) in the promoter regions of target genes as obligate heterodimers with retinoic acid X receptors (RXRs) and recruit co-activators to initiate the transcription of target genes. 18, 19) Type 2 diabetes mellitus is a heterogeneous disease resulting from a dynamic interaction between defects in insulin secretion and insulin action. 20) In animal models and humans affected by this disorder, treatment with thiazolidinediones decreases elevated plasma glucose, triglyceride, and insulin concentrations. 21, 22) Their actions also lead to the stimulation of adipogenesis and the recovery of insulin sensitivity in the target tissues. 22) The antidiabetic effects of thiazolidinediones are directly mediated through binding to PPARg, thereby resulting in an active conformation of the receptor. 23) While the clinical benefits of PPARg agonists in treating type 2 diabetes have been clearly demonstrated, the current generation of glitazones is associated with undesired side-effects, such as weight gain and edema. 24) Thus, there has been significant interest in the design of novel PPARg-modulating drugs that retain efficacious insulin sensitizing properties while minimizing potential adverse effects, especially for long-term use.
In this paper, we describe the biological activities of a series of meroterphenols with the aim of identifying novel PPARg agonists.
Results and Discussion
In the course of the investigation of PPARs activating metabolites from S. yezoense, four new plastoquinones 1-4 were isolated. The plastoquinone derivates were characterized by a junction between a 6-methyl-1,4-hydroquinone and a diterpene chain. The diterpene chains in structure 1-4 are unreported oxygenated linear diterpene analogs. Their structures were designated as meroterphenol A (1), B (2), C (3) and D (4). Meroterphenols A-D have shown potent activation effects on peroxisome proliferator-activated receptor gamma (PPARg). In this paper we describe four new plasto-quinones 1-4, isolated from S. yezoense, and their potent activation effects on PPARs.
Samples of the brown alga S. yezoense were collected from the subtidal zone of the eastern coast of Korea and immediately extracted with acetone. The crude extract was fractionated to seven subfractions by silica vacuum chromatography using n-hexane, ethyl acetate and methanol solvent mixtures. Four new compounds 1-4 were isolated from the ethyl acetate subfraction by C 18 reverse phase HPLC.
Meroterphenol A (1) was isolated as a pale yellowish amorphous powder by C 18 reverse phase Preparative HPLC (t R 68 min) using 30-100% acetonitrile in a water gradient solvent system (total elution time: 120 min). The molecular formula of 1 was assigned as C 27 H 38 O 5 by interpretation of high resolution-electrospray ionization-mass spectra (HR-ESI-MS) ([MϩNa] ϩ m/z 465.2574) and 13 C-NMR data (27 carbon signals). UV absorption bands at 250sh nm, 262sh nm and 291 nm suggested a phenyl chromophore. The IR spectrum displayed absorption bands at 1691 cm Ϫ1 and 3330 cm
Ϫ1
, attributable to a carboxylic acid and an alcohol functionality.
Several substructures of meroterphenol A (1) were assigned through the analyses of 1D-and 2D-NMR data from mainly 1 H-NMR, H COSY spectrum. These data allowed substructures B and C to be typical isoprene units consisting of a vinyl methyl group and an olefinic proton connected to an aliphatic methylene group. In the same manner, substructure D was assigned as an isoprene unit based on the connectivity from an olefinic methine proton at d 5.91 to methylene protons at d 2.50 (2H, dt, Jϭ7.5, 7.5 Hz) through other methylene protons at d 2.10 (2H, m).
As well as enumerated The planar structure of meroterphenol A (1) is therefore composed of diterpene-11-oic acid connected to 6-methyl-1,4-hydroquinone at the C-1 position of a diterpene moiety. Meroterphenol A (1) is new plastoquinone derivative, and a diterpenoid chain including a 14Ј-hydroxy group and a 15Ј-terminal double bond in structure 1 is an unreported oxygenated linear diterpene analogue from natural products.
In the nuclear Overhauser effect spectroscopy (NOESY) spectrum of 1, NOE correlations between H-1Ј to H 3 -20Ј, and between H-5Ј and H 3 -19Ј were observed, but there was no NOE correlation from H-9Ј to H-13Ј and H-14Ј, indicating that all three carbon-carbon double bonds in the diterpenoid chain had trans configuration (Fig. 3) .
Meroterphenol B (2) was isolated as an optically inactive pale yellowish amorphous powder by the same purification procedure as described for 1. The molecular formula of 2 
by interpretation of HR-ESI-MS ([MϪH]
Ϫ m/z 441.2683) and 13 C-NMR data (27 carbon signals). Comprehensive analysis of 1D-and 2D-NMR data allowed us to assemble the planar structure of compound 2, which shared many key NMR signals with those of 1. However, two major differences between compound 2 and 1 were the position of a carbinol group and an olefinic methylene group in the diterpene chain. 1 vinyl methyl groups in the diterpene chain. Thus, meroterphenol B (2) is defined as a 6-methyl-1,4-benzohydroquinone containing 6Ј-hydroxy group and 19Ј-olefinic methylene group in diterpene moiety. Meroterphenol C (3) was isolated as a pale yellowish amorphous powder by the same purification procedure as described for 1.
C-NMR data (27 carbon signals) and ESI-MS ([MϩNa]
ϩ m/z 467.2773) data allowed the assignment of the molecular formula as C 27 H 40 O 5 . The proton NMR data of compound 3 showed five methyl protons and no methylene olefinic proton signals were observed. The HMBC spectrum displayed the correlation from methylene proton signals at d 1.67 (2H, m) and d 1.49 (2H, m), and the methyl proton signal at d 1.18 (3H, s) to the carbinol carbon signal at d C 72.3. Therefore, meroterphenol C (3) is defined as containing a 3Ј-hydroxy group in an oxygenated linear diterpene moiety.
Compounds 1-3 are diastereo-mixtures, which are confirmed by the formation of diastereo-mixture after the treatment of (R)-MTPACl, DMAP and pyridine in the compounds 1-3.
Finally, meroterphenol D (4) was isolated as a pale yellowish amorphous powder. The molecular formula of 4 was assigned as C 27 H 36 O 5 
by interpretation of HR-ESI-MS ([MϪH]
Ϫ m/z 439.2516) and 13 C-NMR data (27 carbon signals). The 1 H-NMR data of compound 4 was similar to that of compound 1. A major difference between 1 and 4 was the presence of a ketone in 4 instead of a hydroxyl group. The HMBC spectrum displayed a correlation from methylene olefinic proton signals at d 6.02 (1H, s) and d 5.82 (1H, s) to a ketone carbon at d C 201.3. The HMBC correlation from two methylene signals at d H 2.47 (2H, t, Jϭ7.5 Hz) and d H 2.85 (2H, t, Jϭ7.5 Hz) to a ketone carbon at d C 201.3 allowed us to assign the position of a ketone in a diterpene chain of 4. Thus, meroterphenol D (4) is a diterpenoid chain including a 14Ј-ketone group and 15Ј-terminal double bond in structure 4.
To search for anti-diabetic effects, we examined the PPARg transcriptional activity in mediating meroterphenol stimulation. As shown in Table 3 , troglitazone treatment was enough to induce transcriptional activation of PPARg; meroterphenols (1-4) treatments also affected the activities, indicating that they might have anti-diabetic potential via PPARg transactivation.
Experimental
General Procedures Optical rotations were measured on a Rudolph Research Analytical Autopol III Automatic Polarimeter using a 1 ml/10 cm cell. Fourier transform (FT)-IR spectra were measured on a Bruker Tensor 27 spectrophotometer. UV spectra were recorded on an Agilent 8453 UV-visible spectrophotometer.
1 H-and 13 C-NMR spectra were obtained on a Varian 500 MHz spectrometer with a carbon-enhanced cold probe in CD 3 CN, operating at 500 MHz ( . Luciferase Reporter Gene Assay CV-1 cells were seeded into 24-well plates and cultured for 24 h before transfection. A DNA mixture containing PPRE-luciferase reporter plasmid (300 ng), pcDNA3-hPPAR-c (30 ng) and internal control plasmid pRL-SV-40 (10 ng) was transfected using TransFast TM transfection reagent (Promega, Madison, WI, U.S.A.). After 24 h of transfection, the cells were incubated for an additional 24 h following treatment with 0.1 mM troglitazone or the indicated concentrations of reversine. The luciferase activity of the cell lysates was measured using Dual-Luciferase ® Reporter Assay System (Promega) according to the manufacturer's instructions. Relative luciferase activity was normalized for transfection efficiency using the corresponding Renilla luciferase activity. 
